Decorating Histones in Polycystic Kidney Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
How Does ADPKD Severity Differ Between Family Members?.
Yeung K, Fryml E, Lanktree M Kidney Int Rep. 2024; 9(5):1198-1209.
PMID: 38707833 PMC: 11068977. DOI: 10.1016/j.ekir.2024.01.053.
References
1.
Patel V, Chowdhury R, Igarashi P
. Advances in the pathogenesis and treatment of polycystic kidney disease. Curr Opin Nephrol Hypertens. 2009; 18(2):99-106.
PMC: 2820272.
DOI: 10.1097/MNH.0b013e3283262ab0.
View
2.
Dang L, Cao X, Zhang T, Sun Y, Tian S, Gong T
. Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2022; 33(9):1708-1725.
PMC: 9529191.
DOI: 10.1681/ASN.2021111425.
View
3.
Lin C, Kurashige M, Liu Y, Terabayashi T, Ishimoto Y, Wang T
. A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed. Sci Rep. 2018; 8(1):2743.
PMC: 5807443.
DOI: 10.1038/s41598-018-20856-6.
View
4.
Padovano V, Kuo I, Stavola L, Aerni H, Flaherty B, Chapin H
. The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function. Mol Biol Cell. 2016; 28(2):261-269.
PMC: 5231895.
DOI: 10.1091/mbc.E16-08-0597.
View
5.
Lakhia R, Mishra A, Biggers L, Malladi V, Cobo-Stark P, Hajarnis S
. Enhancer and super-enhancer landscape in polycystic kidney disease. Kidney Int. 2022; 103(1):87-99.
PMC: 9841439.
DOI: 10.1016/j.kint.2022.08.039.
View